Therapeutics Pillar2022-04-22T01:04:10+00:00

Therapeutics play an important role in all stages of COVID-19 disease: to prevent infection; suppress symptoms and spread of infection to others; treat or prevent symptoms; as a life-saving treatment for severe symptoms; and as a treatment that can speed up recovery.  The Therapeutics Pillar supports access to safe and effective therapeutics of assured quality to save lives from COVID-19 and to minimise its global health and economic threat. The therapeutics pillar is led by Unitaid and Wellcome.

There are currently 3 workstreams within the Therapeutics pillar: Rapid evidence assessment of candidates, market preparedness and adequate deployment in all countries. Each working group has 2 reserved spaces (6 in total) for civil society and communities. The participation and representation of civil society and communities on this pillar is coordinated by Dr Enow Stevens based in Cameroon.

For further information, or any questions, please contact: courtenay@stopaids.org.uk

Clare Rayner
Clare RaynerLong COVID Community Group
1 – Rapid evidence assessment of candidates
Felipe Carvalho
Felipe CarvalhoMSF
1 – Rapid evidence assessment of candidates
Brook Baker
Brook BakerHealth GAP
2 – Market preparedness
Kenly Sikwese
Kenly SikweseAFROCAB
2 – Market preparedness
Dr Zolelwa Sifumba
Dr Zolelwa SifumbaTB Proof
3 – Adequate deployment in all countries
Rachael Crockett
Rachael Crockett
3 – Adequate deployment in all countries

LATEST ACT-A Platform News

Go to Top